We have synthesized new 1, 4-dihydropyridine derivatives having nitrooxyalkylester moieties at the 3- and 5-positions in order to develop potent and long-lasting vasodilators. The antihypertensive activities of these compounds were compared with that of nifedipine. One of them, 2-nitrooxypropyl 3-nitrooxypropyl 2, 6-dimethyl-4-(3-nitrophenyl)-1, 4-dihydro-3, 5-pyridinedicarboxylate (CD-349) was selected for further development. The structure-activity relationship is discussed.
我们合成了新的1,4-二氢
吡啶衍生物,这些衍
生物在3位和5位上具有硝基氧烷基酯基团,以开发有效且持久的血管扩张剂。这些化合物的抗高血压活性与
硝苯地平进行了比较。其中一种化合物,2-硝基氧丙基-
3-硝基氧丙基-2,6-二甲基-4-(3-
硝基苯基)-1,4-二氢-3,5-
吡啶二
羧酸酯(CD-349)被选为进一步开发的对象。我们讨论了结构-活性关系。